BeStock  
Markets › Compare › VBNK vs PRME

VBNK vs PRME

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
VBNK · VersaBank$0.00 ▲ 2.23%
PRME · Prime Medicine$3.55 ▼ 7.55%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

63103142182222Nov 24, '25May 26, '26Nov 20, '26
  • VBNK +76.2%
  • PRME -6.3%

Head to head

MetricVBNKPRME
Price$0.00$3.55
Change today▲ 2.23%▼ 7.55%
Market cap$789.08M$791.62M
Return, 3 months+5.0%+9.2%
Return, year to date+36.6%+2.3%
Return, 1 year+76.5%-2.2%
P/E (TTM)33.2–
P/B2.093.4
P/E percentile vs own 5y99th29th
Dividend yield0.29%–
Revenue growth (YoY, latest qtr)+22.9%+243.9%
Net profit growth (YoY)+52.8%+22.8%
Gross margin––
Operating margin–-2,584.2%
Net margin22.8%-2,497.6%
Return on equity6.2%-207.2%
Analyst target vs. price–+131.0%
Analyst buy share100%100%
RSI (14)3543
30-day volatility48.9%140.8%
Max drawdown, 1 year-21.0%-42.2%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • PRME is the largest of the group by market value.
  • VBNK has returned the most over the past year.
  • PRME is growing revenue fastest.
  • VBNK keeps the most profit per dollar of sales.
  • VBNK has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top